27 Jul 2015 07:41
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Imperial Innovations Group Share News (IVO)
IVO Share
Price
IVO Share
News
IVO Share
Chat
IVO Share
Trades
IVO
Live RNS
IVO Share
Charts
IVO Broker
Ratings
IVO Directors
Deals
IVO Financial
Diary
IVO
Fundamentals
IVO Short
Positions
IVO
Media
Imperial Innovations Group Information
- There is currently no data for IVO
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Imperial Innovations portfolio value rises as companies near IPO
Wed, 16th Oct 2013 11:25
Imperial Innovations accompanied news of a full year rise in its portfolio value with the announcement of a Nasdaq flotation for portfolio company Oxford Immunotec.The university spin-out group said had "a number" of companies in its portfolio also ready for initial public offering (IPO) or trade sale, as the portfolio had increased in value by 21% to £188.2m by the July 31st year-end.Although profits had slipped from £5.1m to £3.8m, net assets crept up from £228.2m to £230.5m with £22.2m invested across 28 portfolio companies. Allergy specialist Circassia, 18% owned by II, posted the largest gain in fair value of £8.5m after highly encouraging clinical trials.Oxford Immunotec, a medical diagnostics company founded with the help of current 8% shareholder II in 2002, plans to raise $86m in its US IPO.The group had available cash of £80m at the year-end, including an undrawn £30m loan from the European Investment Bank.Shares in Imperial Innovations were down 1.4% to 350p at 12:00 on Wednesday.OH
More News
2 Jul 2015 23:01
For first time, gene therapy shows promise in cystic fibrosis
By Kate Kelland LONDON, July 3 (Reuters) - Scientists conducting a major trial of a therapy that replaces the faulty gene responsible for cystic fibrosis say the treatment has showed significant benefit for the first time in patients' lung function. The technique, developed with the t
Read more2 Jul 2015 09:49
Imperial Innovations and Mercia Technologies invest in aluminium business
AIM listed firms Imperial Innovations and Mercia Technologies have together provided £4m to aluminium business Impression Technologies. The duo invested £2.5m and £1.5m respectively in the firm which makes aluminium components for the transport sector. The investment brings Imperial Innovation's s
Read more30 Jun 2015 16:26
Imperial Innovations invests £3m in Abingdon, brings stake to over 30%
British technology transfer and commercialisation company Imperial Innovations Group said it has invested £3m in portfolio company Abingdon Health. On Tuesday, the London-listed group said that, along with existing investors, it had invested £2.5m in Abingdon and now holds a 33.7% stake in the busin
Read more25 Jun 2015 10:17
London mayor suggests $15 bln 'megafund' to boost biotech
LONDON, June 25 (Reuters) - Banks, investors and big drug companies should consider creating a 10-billion-pound ($15.7 billion) "megafund" to help biotech firms in London and across Britain compete with U.S. rivals, London mayor Boris Johnson said on Thursday. Britain is a leader in academi
Read more29 May 2015 15:31
Imperial Innovations' portfolio company appoints new executive chairman
Technology investment group Imperial Innovations Group has appointed Paolo Paoletti as executive chairman of its portfolio company Kesios Therapeutics. London-based Kesios, which develops novel therapeutics for cancer treatments, was created to develop and commercialise certain research from the Dep
Read more